nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0435	0.0809	CbGbCtD
Galantamine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0409	0.0761	CbGbCtD
Galantamine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0409	0.0761	CbGbCtD
Galantamine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.037	0.0688	CbGbCtD
Galantamine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.037	0.0688	CbGbCtD
Galantamine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0319	0.0594	CbGbCtD
Galantamine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.031	0.0576	CbGbCtD
Galantamine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.028	0.0521	CbGbCtD
Galantamine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.028	0.0521	CbGbCtD
Galantamine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0277	0.0514	CbGbCtD
Galantamine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.026	0.0484	CbGbCtD
Galantamine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.026	0.0484	CbGbCtD
Galantamine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0235	0.0437	CbGbCtD
Galantamine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0235	0.0437	CbGbCtD
Galantamine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0203	0.0378	CbGbCtD
Galantamine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0197	0.0367	CbGbCtD
Galantamine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0178	0.0331	CbGbCtD
Galantamine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0178	0.0331	CbGbCtD
Galantamine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0171	0.0318	CbGbCtD
Galantamine—CHRNE—blood—acquired immunodeficiency syndrome	0.00488	0.0402	CbGeAlD
Galantamine—CHRNA6—skin of body—acquired immunodeficiency syndrome	0.0034	0.028	CbGeAlD
Galantamine—CHRNA4—nerve—acquired immunodeficiency syndrome	0.00335	0.0276	CbGeAlD
Galantamine—CHRNA5—vagina—acquired immunodeficiency syndrome	0.00317	0.0261	CbGeAlD
Galantamine—CHRNA5—nervous system—acquired immunodeficiency syndrome	0.00277	0.0228	CbGeAlD
Galantamine—CHRNA5—central nervous system—acquired immunodeficiency syndrome	0.00267	0.022	CbGeAlD
Galantamine—CHRNB3—nervous system—acquired immunodeficiency syndrome	0.00252	0.0207	CbGeAlD
Galantamine—CHRNG—blood—acquired immunodeficiency syndrome	0.00244	0.0201	CbGeAlD
Galantamine—CHRNB3—central nervous system—acquired immunodeficiency syndrome	0.00242	0.0199	CbGeAlD
Galantamine—CHRNG—bone marrow—acquired immunodeficiency syndrome	0.00236	0.0194	CbGeAlD
Galantamine—CHRNA10—lymphoid tissue—acquired immunodeficiency syndrome	0.0022	0.0181	CbGeAlD
Galantamine—CHRNA3—retina—acquired immunodeficiency syndrome	0.00216	0.0177	CbGeAlD
Galantamine—CHRNG—lung—acquired immunodeficiency syndrome	0.00214	0.0176	CbGeAlD
Galantamine—CHRNA5—brain—acquired immunodeficiency syndrome	0.00212	0.0174	CbGeAlD
Galantamine—CHRNA6—nervous system—acquired immunodeficiency syndrome	0.0021	0.0173	CbGeAlD
Galantamine—CHRNA10—blood—acquired immunodeficiency syndrome	0.00207	0.017	CbGeAlD
Galantamine—CHRNA5—lymph node—acquired immunodeficiency syndrome	0.00205	0.0169	CbGeAlD
Galantamine—CHRNA6—central nervous system—acquired immunodeficiency syndrome	0.00202	0.0166	CbGeAlD
Galantamine—CHRNB3—brain—acquired immunodeficiency syndrome	0.00192	0.0158	CbGeAlD
Galantamine—CHRNA10—vagina—acquired immunodeficiency syndrome	0.00192	0.0158	CbGeAlD
Galantamine—CHRNB4—nervous system—acquired immunodeficiency syndrome	0.00191	0.0157	CbGeAlD
Galantamine—CHRNA3—skin of body—acquired immunodeficiency syndrome	0.00189	0.0156	CbGeAlD
Galantamine—CHRNB4—central nervous system—acquired immunodeficiency syndrome	0.00184	0.0151	CbGeAlD
Galantamine—CHRNA1—lymphoid tissue—acquired immunodeficiency syndrome	0.00172	0.0141	CbGeAlD
Galantamine—CHRND—lung—acquired immunodeficiency syndrome	0.0017	0.014	CbGeAlD
Galantamine—CHRNA6—brain—acquired immunodeficiency syndrome	0.00161	0.0132	CbGeAlD
Galantamine—CHRNA3—lymphoid tissue—acquired immunodeficiency syndrome	0.00153	0.0126	CbGeAlD
Galantamine—CHRNB2—blood—acquired immunodeficiency syndrome	0.00149	0.0122	CbGeAlD
Galantamine—CHRNB4—brain—acquired immunodeficiency syndrome	0.00146	0.012	CbGeAlD
Galantamine—BCHE—blood plasma—acquired immunodeficiency syndrome	0.00145	0.0119	CbGeAlD
Galantamine—CHRNB2—bone marrow—acquired immunodeficiency syndrome	0.00144	0.0118	CbGeAlD
Galantamine—CHRNB2—spinal cord—acquired immunodeficiency syndrome	0.00143	0.0118	CbGeAlD
Galantamine—CHRNA7—retina—acquired immunodeficiency syndrome	0.00141	0.0116	CbGeAlD
Galantamine—CHRNB2—vagina—acquired immunodeficiency syndrome	0.00138	0.0113	CbGeAlD
Galantamine—CHRNA2—blood—acquired immunodeficiency syndrome	0.00134	0.011	CbGeAlD
Galantamine—CHRNB2—lung—acquired immunodeficiency syndrome	0.0013	0.0107	CbGeAlD
Galantamine—CHRNA3—lung—acquired immunodeficiency syndrome	0.00126	0.0104	CbGeAlD
Galantamine—CHRNB1—blood—acquired immunodeficiency syndrome	0.00125	0.0103	CbGeAlD
Galantamine—CHRNA10—lymph node—acquired immunodeficiency syndrome	0.00124	0.0102	CbGeAlD
Galantamine—CHRNA7—skin of body—acquired immunodeficiency syndrome	0.00124	0.0102	CbGeAlD
Galantamine—CHRNB2—nervous system—acquired immunodeficiency syndrome	0.00121	0.00993	CbGeAlD
Galantamine—CHRNB1—spinal cord—acquired immunodeficiency syndrome	0.0012	0.00989	CbGeAlD
Galantamine—CHRNA3—nervous system—acquired immunodeficiency syndrome	0.00117	0.00963	CbGeAlD
Galantamine—CHRFAM7A—blood—acquired immunodeficiency syndrome	0.00117	0.0096	CbGeAlD
Galantamine—CHRNB2—central nervous system—acquired immunodeficiency syndrome	0.00116	0.00956	CbGeAlD
Galantamine—CHRNB1—vagina—acquired immunodeficiency syndrome	0.00116	0.00951	CbGeAlD
Galantamine—CHRNA3—central nervous system—acquired immunodeficiency syndrome	0.00113	0.00927	CbGeAlD
Galantamine—CHRNA2—nervous system—acquired immunodeficiency syndrome	0.00109	0.00895	CbGeAlD
Galantamine—CHRNA2—central nervous system—acquired immunodeficiency syndrome	0.00105	0.00862	CbGeAlD
Galantamine—ACHE—spinal cord—acquired immunodeficiency syndrome	0.00104	0.00857	CbGeAlD
Galantamine—CHRNA1—brain—acquired immunodeficiency syndrome	0.001	0.00825	CbGeAlD
Galantamine—CHRNA7—digestive system—acquired immunodeficiency syndrome	0.000989	0.00814	CbGeAlD
Galantamine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000977	0.00804	CbGeAlD
Galantamine—CHRNA4—digestive system—acquired immunodeficiency syndrome	0.000975	0.00803	CbGeAlD
Galantamine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000961	0.00791	CbGeAlD
Galantamine—CHRFAM7A—nervous system—acquired immunodeficiency syndrome	0.000947	0.00779	CbGeAlD
Galantamine—CHRNA7—blood—acquired immunodeficiency syndrome	0.000942	0.00775	CbGeAlD
Galantamine—CHRNB2—brain—acquired immunodeficiency syndrome	0.000923	0.00759	CbGeAlD
Galantamine—CHRFAM7A—central nervous system—acquired immunodeficiency syndrome	0.000911	0.0075	CbGeAlD
Galantamine—CHRNA4—spinal cord—acquired immunodeficiency syndrome	0.000895	0.00737	CbGeAlD
Galantamine—CHRNA3—brain—acquired immunodeficiency syndrome	0.000895	0.00736	CbGeAlD
Galantamine—CHRNB2—lymph node—acquired immunodeficiency syndrome	0.000891	0.00734	CbGeAlD
Galantamine—CHRNA3—lymph node—acquired immunodeficiency syndrome	0.000865	0.00711	CbGeAlD
Galantamine—CHRNA2—brain—acquired immunodeficiency syndrome	0.000832	0.00684	CbGeAlD
Galantamine—CHRNA4—lung—acquired immunodeficiency syndrome	0.000815	0.0067	CbGeAlD
Galantamine—CHRNB1—brain—acquired immunodeficiency syndrome	0.000774	0.00637	CbGeAlD
Galantamine—CHRNA7—nervous system—acquired immunodeficiency syndrome	0.000765	0.00629	CbGeAlD
Galantamine—CHRNA4—nervous system—acquired immunodeficiency syndrome	0.000754	0.00621	CbGeAlD
Galantamine—CHRNB1—lymph node—acquired immunodeficiency syndrome	0.000748	0.00615	CbGeAlD
Galantamine—CHRNA7—central nervous system—acquired immunodeficiency syndrome	0.000736	0.00606	CbGeAlD
Galantamine—CHRNA4—central nervous system—acquired immunodeficiency syndrome	0.000726	0.00598	CbGeAlD
Galantamine—CHRFAM7A—brain—acquired immunodeficiency syndrome	0.000724	0.00595	CbGeAlD
Galantamine—BCHE—skin of body—acquired immunodeficiency syndrome	0.000698	0.00574	CbGeAlD
Galantamine—ACHE—brain—acquired immunodeficiency syndrome	0.000671	0.00552	CbGeAlD
Galantamine—ACHE—lymph node—acquired immunodeficiency syndrome	0.000648	0.00534	CbGeAlD
Galantamine—CHRNA7—brain—acquired immunodeficiency syndrome	0.000584	0.00481	CbGeAlD
Galantamine—CHRNA4—brain—acquired immunodeficiency syndrome	0.000577	0.00474	CbGeAlD
Galantamine—BCHE—digestive system—acquired immunodeficiency syndrome	0.000558	0.00459	CbGeAlD
Galantamine—BCHE—blood—acquired immunodeficiency syndrome	0.000532	0.00437	CbGeAlD
Galantamine—BCHE—bone marrow—acquired immunodeficiency syndrome	0.000514	0.00423	CbGeAlD
Galantamine—BCHE—spinal cord—acquired immunodeficiency syndrome	0.000512	0.00421	CbGeAlD
Galantamine—BCHE—vagina—acquired immunodeficiency syndrome	0.000493	0.00405	CbGeAlD
Galantamine—BCHE—lung—acquired immunodeficiency syndrome	0.000466	0.00383	CbGeAlD
Galantamine—BCHE—nervous system—acquired immunodeficiency syndrome	0.000431	0.00355	CbGeAlD
Galantamine—BCHE—central nervous system—acquired immunodeficiency syndrome	0.000415	0.00342	CbGeAlD
Galantamine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000376	0.00309	CbGeAlD
Galantamine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.00037	0.00304	CbGeAlD
Galantamine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000358	0.00294	CbGeAlD
Galantamine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000352	0.0029	CbGeAlD
Galantamine—BCHE—brain—acquired immunodeficiency syndrome	0.00033	0.00271	CbGeAlD
Galantamine—BCHE—lymph node—acquired immunodeficiency syndrome	0.000319	0.00262	CbGeAlD
Galantamine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000291	0.00239	CbGeAlD
Galantamine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000286	0.00235	CbGeAlD
Galantamine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00028	0.0023	CbGeAlD
Galantamine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000275	0.00226	CbGeAlD
Galantamine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000246	0.000723	CcSEcCtD
Galantamine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000246	0.000721	CcSEcCtD
Galantamine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000246	0.000721	CcSEcCtD
Galantamine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000246	0.000721	CcSEcCtD
Galantamine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000245	0.000721	CcSEcCtD
Galantamine—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000244	0.000718	CcSEcCtD
Galantamine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000244	0.000717	CcSEcCtD
Galantamine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000243	0.000715	CcSEcCtD
Galantamine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.000714	CcSEcCtD
Galantamine—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.000714	CcSEcCtD
Galantamine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000243	0.000714	CcSEcCtD
Galantamine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000243	0.000713	CcSEcCtD
Galantamine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.000713	CcSEcCtD
Galantamine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000242	0.000712	CcSEcCtD
Galantamine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.000711	CcSEcCtD
Galantamine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000242	0.000711	CcSEcCtD
Galantamine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00071	CcSEcCtD
Galantamine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.00071	CcSEcCtD
Galantamine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000241	0.000708	CcSEcCtD
Galantamine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000241	0.000708	CcSEcCtD
Galantamine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000241	0.000707	CcSEcCtD
Galantamine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00024	0.000706	CcSEcCtD
Galantamine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.00024	0.000705	CcSEcCtD
Galantamine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00024	0.000704	CcSEcCtD
Galantamine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000239	0.000702	CcSEcCtD
Galantamine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.000702	CcSEcCtD
Galantamine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.000701	CcSEcCtD
Galantamine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.0007	CcSEcCtD
Galantamine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.0007	CcSEcCtD
Galantamine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.0007	CcSEcCtD
Galantamine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000238	0.000698	CcSEcCtD
Galantamine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.000698	CcSEcCtD
Galantamine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.000698	CcSEcCtD
Galantamine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.000696	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000237	0.000695	CcSEcCtD
Galantamine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000236	0.000693	CcSEcCtD
Galantamine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000236	0.000692	CcSEcCtD
Galantamine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000236	0.000692	CcSEcCtD
Galantamine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000236	0.000692	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000235	0.000691	CcSEcCtD
Galantamine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000235	0.000691	CcSEcCtD
Galantamine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000234	0.000687	CcSEcCtD
Galantamine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000234	0.000686	CcSEcCtD
Galantamine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.000686	CcSEcCtD
Galantamine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.000685	CcSEcCtD
Galantamine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.000684	CcSEcCtD
Galantamine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000232	0.000683	CcSEcCtD
Galantamine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000232	0.000683	CcSEcCtD
Galantamine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000232	0.000682	CcSEcCtD
Galantamine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.000681	CcSEcCtD
Galantamine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000681	CcSEcCtD
Galantamine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000231	0.00068	CcSEcCtD
Galantamine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000231	0.00068	CcSEcCtD
Galantamine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.000679	CcSEcCtD
Galantamine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000231	0.000678	CcSEcCtD
Galantamine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.000677	CcSEcCtD
Galantamine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000677	CcSEcCtD
Galantamine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00023	0.000674	CcSEcCtD
Galantamine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.000674	CcSEcCtD
Galantamine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.000674	CcSEcCtD
Galantamine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.000674	CcSEcCtD
Galantamine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.000672	CcSEcCtD
Galantamine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000228	0.00067	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.000669	CcSEcCtD
Galantamine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.000668	CcSEcCtD
Galantamine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000227	0.000666	CcSEcCtD
Galantamine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.000664	CcSEcCtD
Galantamine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000225	0.000662	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.000661	CcSEcCtD
Galantamine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.00066	CcSEcCtD
Galantamine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000225	0.00066	CcSEcCtD
Galantamine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.000659	CcSEcCtD
Galantamine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000224	0.000659	CcSEcCtD
Galantamine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000224	0.000659	CcSEcCtD
Galantamine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.000658	CcSEcCtD
Galantamine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.000657	CcSEcCtD
Galantamine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000224	0.000657	CcSEcCtD
Galantamine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000224	0.000657	CcSEcCtD
Galantamine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000224	0.000657	CcSEcCtD
Galantamine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000223	0.000655	CcSEcCtD
Galantamine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000223	0.000655	CcSEcCtD
Galantamine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.000654	CcSEcCtD
Galantamine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000223	0.000654	CcSEcCtD
Galantamine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000223	0.000654	CcSEcCtD
Galantamine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.000652	CcSEcCtD
Galantamine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.000652	CcSEcCtD
Galantamine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000651	CcSEcCtD
Galantamine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.000649	CcSEcCtD
Galantamine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000221	0.000649	CcSEcCtD
Galantamine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000221	0.000649	CcSEcCtD
Galantamine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000221	0.000648	CcSEcCtD
Galantamine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00022	0.000647	CcSEcCtD
Galantamine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.000645	CcSEcCtD
Galantamine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000219	0.000645	CcSEcCtD
Galantamine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.000643	CcSEcCtD
Galantamine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.000643	CcSEcCtD
Galantamine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.000643	CcSEcCtD
Galantamine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000219	0.0018	CbGeAlD
Galantamine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.000641	CcSEcCtD
Galantamine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.00064	CcSEcCtD
Galantamine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.000639	CcSEcCtD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.000639	CcSEcCtD
Galantamine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.000636	CcSEcCtD
Galantamine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000216	0.000635	CcSEcCtD
Galantamine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000216	0.000635	CcSEcCtD
Galantamine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000216	0.000635	CcSEcCtD
Galantamine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.000634	CcSEcCtD
Galantamine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000216	0.000634	CcSEcCtD
Galantamine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.000633	CcSEcCtD
Galantamine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000215	0.000632	CcSEcCtD
Galantamine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.000631	CcSEcCtD
Galantamine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000629	CcSEcCtD
Galantamine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000214	0.000628	CcSEcCtD
Galantamine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000214	0.000628	CcSEcCtD
Galantamine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.000628	CcSEcCtD
Galantamine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.000627	CcSEcCtD
Galantamine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.000627	CcSEcCtD
Galantamine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000213	0.000626	CcSEcCtD
Galantamine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.000626	CcSEcCtD
Galantamine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000213	0.000626	CcSEcCtD
Galantamine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000213	0.000625	CcSEcCtD
Galantamine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000625	CcSEcCtD
Galantamine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000213	0.000624	CcSEcCtD
Galantamine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000212	0.000622	CcSEcCtD
Galantamine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000212	0.000622	CcSEcCtD
Galantamine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000622	CcSEcCtD
Galantamine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000211	0.000621	CcSEcCtD
Galantamine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000211	0.00062	CcSEcCtD
Galantamine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000211	0.00062	CcSEcCtD
Galantamine—Rash—Abacavir—acquired immunodeficiency syndrome	0.00021	0.000617	CcSEcCtD
Galantamine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00021	0.000616	CcSEcCtD
Galantamine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.000616	CcSEcCtD
Galantamine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000209	0.000613	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000612	CcSEcCtD
Galantamine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000208	0.000611	CcSEcCtD
Galantamine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.000607	CcSEcCtD
Galantamine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000606	CcSEcCtD
Galantamine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000604	CcSEcCtD
Galantamine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.000604	CcSEcCtD
Galantamine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.000604	CcSEcCtD
Galantamine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.000603	CcSEcCtD
Galantamine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.0006	CcSEcCtD
Galantamine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.0006	CcSEcCtD
Galantamine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.000599	CcSEcCtD
Galantamine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.000598	CcSEcCtD
Galantamine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.000597	CcSEcCtD
Galantamine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.000596	CcSEcCtD
Galantamine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.000594	CcSEcCtD
Galantamine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000202	0.000592	CcSEcCtD
Galantamine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000201	0.000592	CcSEcCtD
Galantamine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000591	CcSEcCtD
Galantamine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000201	0.000591	CcSEcCtD
Galantamine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000201	0.00059	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000589	CcSEcCtD
Galantamine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000588	CcSEcCtD
Galantamine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000584	CcSEcCtD
Galantamine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000584	CcSEcCtD
Galantamine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000198	0.000581	CcSEcCtD
Galantamine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.00058	CcSEcCtD
Galantamine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.00058	CcSEcCtD
Galantamine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000579	CcSEcCtD
Galantamine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000196	0.000576	CcSEcCtD
Galantamine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000576	CcSEcCtD
Galantamine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000574	CcSEcCtD
Galantamine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000574	CcSEcCtD
Galantamine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.000574	CcSEcCtD
Galantamine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.000574	CcSEcCtD
Galantamine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000194	0.000571	CcSEcCtD
Galantamine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000569	CcSEcCtD
Galantamine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000562	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000562	CcSEcCtD
Galantamine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.000559	CcSEcCtD
Galantamine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000558	CcSEcCtD
Galantamine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000557	CcSEcCtD
Galantamine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000557	CcSEcCtD
Galantamine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.000553	CcSEcCtD
Galantamine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000553	CcSEcCtD
Galantamine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.000553	CcSEcCtD
Galantamine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000187	0.000549	CcSEcCtD
Galantamine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000187	0.000549	CcSEcCtD
Galantamine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000549	CcSEcCtD
Galantamine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000548	CcSEcCtD
Galantamine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000185	0.000544	CcSEcCtD
Galantamine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000185	0.000544	CcSEcCtD
Galantamine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000185	0.000544	CcSEcCtD
Galantamine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000543	CcSEcCtD
Galantamine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000184	0.000541	CcSEcCtD
Galantamine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000536	CcSEcCtD
Galantamine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.000535	CcSEcCtD
Galantamine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000532	CcSEcCtD
Galantamine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000532	CcSEcCtD
Galantamine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000531	CcSEcCtD
Galantamine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000181	0.000531	CcSEcCtD
Galantamine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000531	CcSEcCtD
Galantamine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000531	CcSEcCtD
Galantamine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000528	CcSEcCtD
Galantamine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000527	CcSEcCtD
Galantamine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.000521	CcSEcCtD
Galantamine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.000519	CcSEcCtD
Galantamine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000175	0.000513	CcSEcCtD
Galantamine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000511	CcSEcCtD
Galantamine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000511	CcSEcCtD
Galantamine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000174	0.000511	CcSEcCtD
Galantamine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000508	CcSEcCtD
Galantamine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000172	0.000506	CcSEcCtD
Galantamine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000172	0.000506	CcSEcCtD
Galantamine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000504	CcSEcCtD
Galantamine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000171	0.000503	CcSEcCtD
Galantamine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.000502	CcSEcCtD
Galantamine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.000497	CcSEcCtD
Galantamine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000495	CcSEcCtD
Galantamine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000487	CcSEcCtD
Galantamine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000487	CcSEcCtD
Galantamine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000164	0.000482	CcSEcCtD
Galantamine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.000482	CcSEcCtD
Galantamine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.00048	CcSEcCtD
Galantamine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.000478	CcSEcCtD
Galantamine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.000478	CcSEcCtD
Galantamine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000162	0.000477	CcSEcCtD
Galantamine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000476	CcSEcCtD
Galantamine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000162	0.000475	CcSEcCtD
Galantamine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.000464	CcSEcCtD
Galantamine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000157	0.000462	CcSEcCtD
Galantamine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000459	CcSEcCtD
Galantamine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000458	CcSEcCtD
Galantamine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000457	CcSEcCtD
Galantamine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.000455	CcSEcCtD
Galantamine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000454	CcSEcCtD
Galantamine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.000451	CcSEcCtD
Galantamine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000444	CcSEcCtD
Galantamine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000442	CcSEcCtD
Galantamine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000442	CcSEcCtD
Galantamine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000431	CcSEcCtD
Galantamine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000427	CcSEcCtD
Galantamine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000427	CcSEcCtD
Galantamine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000423	CcSEcCtD
Galantamine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000423	CcSEcCtD
Galantamine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000422	CcSEcCtD
Galantamine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000421	CcSEcCtD
Galantamine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000411	CcSEcCtD
Galantamine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000408	CcSEcCtD
Galantamine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000407	CcSEcCtD
Galantamine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000407	CcSEcCtD
Galantamine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000405	CcSEcCtD
Galantamine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000399	CcSEcCtD
Galantamine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000392	CcSEcCtD
Galantamine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000389	CcSEcCtD
Galantamine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000388	CcSEcCtD
Galantamine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000386	CcSEcCtD
Galantamine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000384	CcSEcCtD
Galantamine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000366	CcSEcCtD
